Medicines and Related Substances Act, 1965
R 385
Subregulation (15) Counterparty credit risk exposure and matters related thereto |
[Subregulation (15) Heading substituted by section 3(i) of Notice No. 1427, GG44048, dated 31 December 2020 - effective 1 January 2021]
Subregulation (15)(c) Matters relating to minimum required capital and reserve funds for CVA risk